Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
Clinical trial NCT03402386 · COMPLETED
Trial details
- NCT number
- NCT03402386
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-03
- Primary completion
- 2018-11-22
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.